ArticleInternational urology and nephrology2026
Targeting immunosenescence: a new frontier for mineralocorticoid receptor antagonism in chronic kidney disease.
Chenhang Fu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it